INTRODUCTION
Cerebral microbleeds (CMBs) are small-sized (less than 10 mm in diameter), focal, perivascular, hemosiderin depositions that have emerged as an important marker of brain small vessel disease. These lesions are easily depicted by Gradient echo T2* (GRE-T2*) magnetic resonance imaging (MRI) and susceptibility weighted imaging (SWI) sequences as round or ovoid hypodense foci within the cerebral parenchyma.
1 SWI can depict iron depositions and small vessels with greater detail than GRE, thus potentially resulting in CMB's overestimation. 2 However, a comparison study between GRE and SWI sequences in patients with cerebral amyloid angiopathy (CAA) as well as in healthy non-cerebral amyloid angiopathy controls concluded the population-based Rotterdam Study comprising of 1,062 non-demented individuals with a mean age of 69.6 years, the prevalence of CMBs was even higher and increased further with advancing age. Therefore, for any number of CMBs, the authors found a prevalence of 17.8% and 38.3%, and for multiple CMBs of 5.4% and 23.3% in individuals aged 60-69 and 80-97 years old, respectively. The presence of lacunar infarcts and of white matter lesions on brain MRI, as well as patient's cardiovascular risk factors were associated with CMBs of deep or infratentorial location. On the contrary, apolipoprotein E (APOE) ε4 carriers displayed more often multiple lobar microhemorrhages. It is noteworthy that lower cholesterol levels were associated with the presence of both lobar and deep or infratentorial microbleeds. 5 In the Framingham Heart Study, CMBs were present in 8.8% among 1,965 participants, yet this study population was younger, with a mean age of 66.5 years. Again, CMBs were more common in men and their numbers increased with advancing age. Arterial hypertension was linked to deep and mixed (lobar and deep) CMBs, whereas APOE ε4 allele with lobar location. Moreover, statins increased the risk of lobar and mixed location CMBs. 6 A more recent study reported prevalence of 8%
and 16% for deep/mixed and lobar CMBs, respectively, with chronic brain ischemic lesions correlating well with the presence of CMBs in deep location. 7 The largest population study analyzed 2,602 individuals with a mean age of 74.6 years. CMBs were found in 16.8% (single 12.0% and multiple 2.6%) and were more common in older and male participants, APOE ε4 allele carriers, hypertensives, statin and antithrombotic medication users, individuals with lower total cholesterol levels and higher total brain volume, and those with cardiovascular disease and ischemic lesions on brain MRI. 8 Therefore, CMBs are a common MRI finding, and several clinical, demographic and genetic factors contribute to their development (Table 1) .
HISTOPATHOLOGICAL AND IMAGING FIND-INGS
Hypodense foci on T2-weighted MRI sequences were first associated with hemosiderin deposits in the studies by Tanaka et al. 9 and Fazekas et al. 1 in 1999.
Both studies used T2*-weighted gradient-echo pulse sequences, whereas the autopsy examination identified these hypodense foci as hemosiderin deposits around arteriosclerotic microvessels. There were occasionally small infarctions surrounding the lesions as well as focal accumulations of hemosiderin-containing macrophages. 1, 9 Micro-dissections, micro-aneurysms, micro-calcifications and arteriolar pseudocalcifications may be falsely perceived as CMBs on brain imaging.
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On MRI-SWI imaging, CMBs appear as hypointense small areas and can be differentiated from focal calcifications by the use of phase SWI sequences where the later still preserve hypointense features in contrast with the former that develop a positive (high) signal. 11 In the manuscript by Azad et al. 11 the following parameters for axial 3D SWI sequences were applied: repetition time/ A recent study investigated the correlation between MRI-detected CMBs and histopathologically confirmed microbleeds. A total of 25 autopsy cases had T2* sequences displaying at least one CMB. The sensitivity of MRI-T2* sequences in detecting 'true' CMBs was 51.9%, and the false negative rate was 48.1%. The low accuracy of MRI in this study may reflect the limited diagnostic value of T2* sequences in detecting CMBs compared to SWI.
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CMBS AND RISK OF INTRACEREBRAL HEMOR-RHAGE AND ISCHEMIC STROKE
As a marker of small vessel disease, the burden of CMBs in brain MRI is expected to increase the risk of future acute neuro-vascular events. Similarly, patients with previous ischemic or hemorrhagic stroke are more likely to harbor CMBs. In these settings, individuals with recent ischemic stroke or transient ischemic attack (TIA) and CMBs have a significantly elevated risk of subsequent events, both hemorrhagic and ischemic with odds ratios of 8.52 and 1.55, respectively. 13 A recent meta-analysis found increased odds for stroke recurrence after ischemic stroke or TIA in the presence of CMBs, with the risk of intracerebral hemorrhage (ICH) being again higher. 14 The same study analyzed also cohorts without previous stroke and found that CMBs were associated with higher risk of ischemic, and mainly, hemorrhagic stroke (odds ratio 3.59 and 7.46, respectively). In addition, MRI-based CMB detection was an independent predictor of all-cause mortality.
14 Another meta-analysis of prospective studies on ICH recurrence underscored the importance of CMB burden and distribution. Therefore, patients with CAA-related hemorrhage were in greater recurrence risk compared to those with CAA-unrelated hemorrhage. Moreover, multiple CMBs predicted recurrence in both CAA-related and unrelated ICH cases, however, for the later the association was significant only for >10 CMBs. 15 Patients with ischemic stroke and atrial fibrillation should receive long term anticoagulation. The MRIbased detection of CMBs might assist in defining the risk of hemorrhagic intracranial complications. Indeed, CMBs in anticoagulated patients substantially increase the risk of ICH, especially when multiple (>5 CMBs). 16 The direct oral anticoagulants (DOACs) have shown to cause significantly less brain hemorrhages than vitamin K antagonists. 17 In addition, in patients with anticoagulation-related brain hemorrhage, DOACs might be associated with lower hematoma volumes and less severe neurological deficits. 18 20 A recent meta-analysis comprising of 2,479 patients documented a substantial risk induction of symptomatic hemorrhagic transformation in the presence of CMBs at the pre-treatment MRI. This association was even more powerful for cases with >10 microbleeds. 21 Therefore, in the most recent guidelines from the American Heart Association/American Stroke Association there is a statement referring to multiple CMBs that, when more than 10, render the benefits of intravenous thrombolysis uncertain.
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COMMON CAUSES OF CMBS
Brain microhemorrhages in lobar and subcortical distribution are linked to APOE ε2 and APOE ε4 genotype, beta-amyloid deposition burden on 11C-PiB positron emission tomography, and histopathological evidence of CAA. 10 The Boston criteria define probable or possible CAA when patients aged >55 years harbor multiple or single lobar, cortical, or cortico-subcortical hemorrhages on computed tomography/MRI, without evidence of an alternative cause for intracranial hemorrhage. 23 The diagnosis of CAA is further supported by the presence of cortical superficial siderosis on T2* or SWI sequences. Increased volume of white matter hyperintensities indicating leukoaraiosis is another imaging feature of CAA that is suggestive of a chronic state of cerebral hypoperfusion and ischemia ( Fig. 1 ). 24 The prevalence of CAA pathology in community based studies is strictly age-related and ranges from 8% to 49% depending also to the origin of the population analysed. 25 The induction of an inflammatory angiocentric response around or within the wall of small and medium sized cortical and leptomeningeal arteries with beta-amyloid depositions results in CAA-related inflammation or angiitis. 26 The imaging characteristics include cortical and subcortical tumefactive confluent edema without infarcts, and at least one cerebral macro-or microbleed, or cortical superficial siderosis. The most common symptoms are rapidly progressive cognitive decline, focal neurological deficits, seizures, and headaches. The prognosis is generally poor with high rates of morbidity and mortality (up to 60%). 27 The patients are treated with corticosteroids and cytostatic agents. In Fig. 2 , we present a case of CAA-related inflammation with a marked response to corticosteroids. Conversely, the presence and burden of CMBs, located predominantly in deep cerebral areas, correlate well with the degree of arterial hypertension and the consequences of hypertension on other end organs, such as the left cardiac ventricule. 28 In patients suffering from ischemic stroke attributed to hypertension 30 CMBs are commonly encountered after head trauma. The lesions are usually seen in the frontal, temporal and parietal lobes. In cases with a history of more severe head impact, MRI may disclose microhemorrhages in the corpus callosum and deep white matter tracts, 
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and these findings are associated with diffuse axonal injury and subsequent cognitive impairment, predominantly involving executive functions and attention. 29, 31 UNCOMMON CAUSES OF CMBS
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)
CADASIL is a progressive, non-atherosclerotic, amyloid-negative, hereditary, small vessel disease caused by mutations in the Notch3 gene. The syndrome was first described 30 years ago in a French family. 32 Brain MRI discloses: 1) white matter hyperintensities typically involving, among others areas, the external capsule and the anterior temporal poles; 2) lacunar infarcts in the centrum semi-ovale, thalamus, basal ganglia, and pons; and 3) CMBs located predominantly in the thalami (Fig.  3) . 33 The first report for the presence of brain microhemorrhages on T2*-weighted sequences in patients with CADASIL and their family members found a prevalence of 31%, with the lesions located more often within the thalamus. 34 A subsequent study reported an ever higher prevalence of CMBs (69%) located predominantly in cortical-subcortical regions, the white matter, thalamus, and brainstem. Postmortem examination of 7 brains revealed accumulations of hemosiderin-containing macrophages corresponding to the imaging related microhemorrhages. 35 A recent study of 125 patients with CADASIL found a strong correlation of CMBs with age. Hemorrhagic stroke, dementia, urge incontinence, and statin use were also associated with CMB burden after adjustment for age. 36 Arterial hypertension further increases CMB burden, which, in turn, is associated with an elevated risk of intracerebral hemorrhage and ischemic stroke. Therefore, strict blood pressure control, smoking abstention, and statin avoidance are recommended for individuals with CADASIL. However, the pathophysiological mechanisms related to CMBs in these individuals may be at least partially distinct from those mechanisms associated to leukoaraiosis and lacunar infarcts. Indeed, a recent study found no significant correlation between CMB and other imaging features of cerebral small vessel disease. On the contrary, the authors documented the well-known association of CMBs with age. 37 Thus, an effective prevention strategy for the deceleration of CMB development in CADASIL patients is currently unavailable.
Fabry disease
Fabry disease is an X-linked lysosomal storage disorder caused by alpha-galactosidase A gene mutation resulting in deficient activity of alpha-galactosidase A and progressive lysosomal deposition of globotriaosylceramide in cells throughout the body. The disease may affect the peripheral nerves, skin, kidneys, brain and heart. 38 Brain MRI shows evidence of small vessel disease, including white matter hyperintensities and CMBs, in almost half of the patients. 39 CMBs are found in 30% of cases, more frequently in males, individuals with white matter hyperintensities, and chronic kidney disease. 
Type IV collagen alpha 1 (COL4A1) mutations
Mutations in the gene coding for COL4A1 were initially linked to porencephaly in humans. Later, phenotypic observations in a French family harboring COL4A1 mutations lead to a connection with brain small vessel disease. Diffuse leukoencephalopathy, dilated perivascular spaces, lacunes, and CMBs represent typical brain MRI findings. 41 Sporadic cases with spontaneous ICH have been found to harbor COL4A1 mutations that lead to defective type IV collagen deposition within the basement membrane of the vessel wall, thus to the development of fragile cerebral vessels that are prone to rupture after minimal trauma, intense activity or anticoagulation treatment. 42 A study of 52 carriers of COL4A1 mutations reported increased stroke rates, both ischemic and hemorrhagic, with a mean age at presentation of 36 years. Hemorrhages were subcortical and ischemic strokes lacunar, indicating small vessel pathology. The location of CMBs was subcortical. Kargiotis O, et al. Causes of Cerebral Microbleeds be idiopathic or secondary to a variety of causes, with the most common being arterial hypertension/hypertasic crisis, transplantation-related immunosuppressive medication, chemotherapy, renal disease and preeclampsia. 44 CMBs have been reported in the context of Tacrolimus and thrombotic thrombocytopenic purpura-related PRES. 45 
Infective endocarditis
Infective endocarditis is a potentially lethal clinical condition, which may provoke systemic embolization in 22% to 50% of cases, with up to 65% of embolic events involving the central nervous system. 48 CMBs, both in cortical and subcortical locations, are common, detected in up to 57% of cases, and their presence is a predictor of an impending intracranial hemorrhage. 49, 50 Cerebral microhemorrhages on brain MRI are described even in the majority of neurologically asymp- 
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tomatic individuals with infective endocarditis. 51 Another study found that prosthetic heart valve-associated infective endocarditis is strongly related to the presence of CMBs. 52 
Moyamoya disease
Moyamoya disease is a chronic, steno-occlusive cerebrovascular disease of unknown etiology. The typical imaging features include steno-occlussive lesions of the terminal intracranial internal carotid arteries, with a subsequent development of an abnormal vascular network at the base of the brain. The disease is more commonly encountered in Eastern Asian. There are two different age groups that show pick-incidence of disease presentation, the first between 10-20 and the second between 35-50 years of age. Recurrent ischemic strokes due to hypoperfusion, and intracranial hemorrhages, often intraventricular, may develop over the course of the disease. 53 CMBs, located in deep and periventricular regions, are seen in 28-46% of cases although a recent report concerning a European moyamoya patient cohort found a lower prevalence of 12.9%. [54] [55] [56] Their presence is associated with dilated anterior choroidal or posterior communicating arteries. Periventricular CMBs increase the risk of intraventricular hemorrhage.
Irradiation
Brain irradiation is widely used as primary or adjunctive therapy of central nervous system tumors. However, several early or late complications might occur, such as tissue necrosis, white matter injury, brain atrophy, mineralization, microangiopathy, telangiectasia, optic neuropathy, and large vessel vasculopathy. 57 Radiation-induced vascular injury often involves the small arteries and capillaries leading to endothelial injury, vascular ectasia and microbleeds. An MRI study of 34 patients detected CMBs in 16 (47%). The time latency between radiation exposure and imaging was 3 months to 9 years, whereas a significant correlation between irradiation dose and CMB prevalence was noticed. 58 Recently, a latency of 8-22 months between irradiation for glioma and initial appearance of microbleeds has been reported, whereas 2 years after exposure the numbers of CMBs substantially increased. Noticeably, patients that had received antiangiogenic agents had significantly fewer microbleeds. 59 The clinical significance of irradiation-induced CMBs has been addressed in several studies of various cancer types, including pediatric tumors, that have documented an association of CMBs with cognitive decline.
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Obstructive sleep apnea
Obstructive sleep apnea has a high prevalence in general population, whereas it is considered as an important risk factor of cardiovascular disease and mortality. 63 Recently, moderate to severe obstructive sleep apnea has been linked to CMBs, since higher apnea-hypopnea index was an independent predictor of CMBs after adjustment for age, hypertension, diabetes, and cardiovascular disease. 63, 64 Whether individuals with obstructive sleep apnea harboring CMBs are in greater risk of hemorrhagic or ischemic stroke remains to be elucidated.
Cocaine use
Cocaine abuse is a well-known cause of stroke, both ischemic and hemorrhagic. Cocaine intake can result in acute arterial hypertensive peaks, as well as may induce cerebral vasoconstriction and vasculitis, with bloodbrain barrier disruption and neuroinflammation. 65 Particularly small cerebral vessels might become leaky and fragile. Shoamanesh et al. 66 evaluated the MRI scans from 104 young patients (≤49 years) with a history of stroke. CMBs were detected in 17%, and among other risk factors examined, subjects with positive serum toxicology for cocaine were more likely to develop new microbleeds on repeat MRI (67% vs. 13%). 66 
Hematological disorders
Thrombotic thrombocytopenic purpura (TTP) and disseminated intravascular coagulation (DIC) are rare hematological disorders with frequent neurological manifestations, such as seizures, ischemic and hemorrhagic stroke. TTP affects the brain through a multisystemic thrombotic microangiopathy and microthrobi formation. Cortical-subcortical as well as deep gray/ white matter CMBs have been described on MRI-GRE 88 http://www.j-nn.org (Fig. 4A-D) . T2-sequences were unremarkable except from one lacunar lesion in the left centrum-semiovale and no further evidence of hypertensive small vessel disease (Fig. 4E, F) . 
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The second case refers to a 65-year-old male with a 10-year history of extensive aortic dissection DeBakey type I, as well as idiopathic arterial hypertension. He underwent urgent brain-MRI because of acute onset left-sided hemiparesis attributed to ischemic stroke, caused by acute thrombosis of the pseudolumen of the dissected aorta and subsequent extension of the chronic dissection with subocclusion of the innominate artery. SWI sequences disclosed multiple (n=10) CMBs located predominantly in hemispheric cortical and subcortical areas with a pattern of preferential involvement of watershed arterial territories (Fig. 5B-F) . Diffusion-weighted sequences disclosed an acute, right frontal-parietal-temporal cortical ischemic stroke, with no further evidence of hypertensive small vessel disease (Fig. 5A) . In both patients, extensive work-up found no damage in other end organs (retina, kidneys, and heart) from chronic hypertension. Moreover, the family history and clinical examination were not suggestive of any hereditary connective tissue disease.
Discussion
Although the majority of patients with a history of aortic dissection are also hypertensives, CMBs in our patients with aortic dissection displayed a different pattern of spatial distribution compared to that seen in patients with severe arterial hypertension, with more Kargiotis O, et al. Causes of Cerebral Microbleeds frequent involvement of frontal and occipital lobes and less of deep grey and white matter tracts, a pattern suggestive of preferential localization of CMBs in watershed subcortical arterial zones. A distinct mechanism seems to be responsible for the CMBs development in individuals with aortic dissection. Indeed, CMBs might be a result of fat embolism, a shower of cholesterol microemboli produced from the injured intimal layer of the aorta during acute dissection, subsequently becoming embedded into the cerebral microvasculature. Interestingly, distal cholesterol crystal embolism has been described following aortic dissection. 73, 74 The proposed mechanism of CMB development after aortic dissection is similar to that of the fat embolism syndrome, which is typically precipitated by major trauma with fracture of long bones leading to fat from the bone marrow released into the blood stream. In such cases, MRI-SWI disclose multiple, small sized (<3 mm) CMBs in watershed territories located in the hemispheric white matter and in the gray and white matter of the cerebellum. 29 The incidence of cerebral fat embolism in patients with long bone fracture is low, between 0.9% and 2.2%. 75 An autopsy study of a patient who sustained multiple fractures in an automobile accident and subsequently developed fat embolism syndrome revealed abundant CMBs, up to 2-3 mm in diameter, diffusely distributed in the cerebral white matter (centrum semiovale, deep white matter, internal capsule), but largely sparing the cortex and deep nuclei. However, in the cerebellum the CMBs involved both the white and gray matter. Few hemorrhages were also detected in the brain stem and spinal cord. Yet, the detection of white matter petechiae does not provide a definitive diagnosis of cerebral fat embolism, since an autopsy examination with light microscopy is required. These microhemorrhages occur when fat globules occlude the microvasculature leading to necrosis and hemorrhage in the surrounding brain parenchyma. 76 Thus, it is suggested that T2*-weighted gradient-echo MRI sequences may serve as a powerful diagnostic tool for the early confirmation of cerebral fat embolism. 77 Interestingly, cerebral fat embolism, appearing as multiple CMBs on T2* GRE sequences, has been reported in patients with β-Thalassemia as a consequence of bone marrow infarcts and necrosis. 78 Larger case series are needed to confirm the possible association between CMBs and aortic dissection. The broad differential diagnosis of diffuse CMBs on brain MRI may also include the history of aortic dissection. In such cases, the patient's history in association with the pattern of spatial distribution of the lesions on MRI-SWI may guide the final diagnosis.
CONCLUSION
CMBs are relatively common findings disclosed by T2* GRE and SWI MRI sequences. Table 2 presents the causes of MRI-detected CMBs. In the majority of cases they represent imaging markers of small vessel disease 
